HLA-B27 subtype polymorphism and CTL epitope choice: Studies with EBV peptides link immunogenicity with stability of the B27:peptide complex

Journal of Immunology

Volumn 161, Issue 10, 1998, Pages 5252-5259

  Brooks, Jill M ^a   Colbert, Robert A ^b   Mear, John P ^b   Leese, Alison M ^a   Rickinson, Alan B ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA B27 ANTIGEN; VIRUS ANTIGEN;

ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; EPSTEIN BARR VIRUS; HUMAN; MOLECULAR STABILITY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION;

ANTIGEN PRESENTATION; CYTOTOXICITY, IMMUNOLOGIC; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HALF-LIFE; HLA-B27 ANTIGEN; HUMANS; MACROMOLECULAR SUBSTANCES; OLIGOPEPTIDES; POLYMORPHISM, GENETIC; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VIRAL PROTEINS;

EID: 0032533802     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Townsend, A. R. M., J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith, and A. J. McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44: 959.
2. Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. Structure of the human class I histocompalibility antigen, HLA-A2. Nature 329:506.
3. Bjorkmann, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329:512.
4. Townsend, A., and H. Bodmer. 1989. Antigen recognition by class I-restricted lymphocytes. Annu. Rev. Immunol. 7:601.
5. Falk, K., O. Rötzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
6. López de Castro, J. A. 1998. The pathogenetic role of HLA-B27 in chronic arthritis. Curr. Opin. Immunol. 10:59.
7. Jardetsky, T. S., W. S. Lane, R. A. Robinson, D. R. Madden, and D. C. Wiley. 1991. Identification of self peptides bound to purified HLA-B27. Nature 353:326.
8. Rötzschke, O., K. Falk, S. Stevanovic, G. Gnau, G. Jung, and H.-G. Rammensee. 1994. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs, Immunogenetics 39:74.
9. Madden, D. R., J. C. Gorga, J. L. Strominger, and D. C. Wiley. 1991. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 353:321.
10. Madden, D. R., J. C. Gorga, J. L. Strominger, and D. C. Wiley. 1992. The three-dimensional structure of HLA-B27 at 2.1A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70:1035.
11. Bennink, J. R., and J. W. Yewdell. 1988. Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins: high frequency of non-responder MHC class I alleles. J. Exp. Med. 168:1935.
12. Braciale, T. J., M. T. Sweetser, L. A. Morrison, D. J. Kittlesen, and V. L. Braciale. 1989. Class I major histocompatibility complex-restricted cytolytic T lymphocytes recognize a limited number of sites on the influenza hemagglutinin. Proc. Natl. Acad. Sci. USA 86:277.
13. Deng, Y., J. W. Yewdell, L. C. Eisenlohr, and J. R. Bennink. 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158:1507.
14. Niederman, G., S. Butz, H. G. Ihienfeldt, R. Grimm, M. Lucchiari, H. Hoschützky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility class I molecules. Immunity 2:289.
15. Del Val, M., H.-J. Schlicht, T. Ruppert, M. J. Reddehase, and U. H. Koszinowski. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66: 1145.
16. Ossendorp, F., M. Eggers, A. Neisig, T. Ruppert, M. Groettrup, A. Sijts, E. Mengedé, P.-M. Kloetzel, J. Neefjes, U. Koszinowski, and C. Melief. 1996. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 5:115.
17. Heemels, M.-T., T. N. M. Scumacher, K. Wonigeit, and H. L. Ploegh. 1993. Peptide translocation by variants of the transporter associated with antigen processing. Science 262:2059.
18. Shepherd, J. C., T. N. M. Schumacher, P. G. Ashton-Rickardt, S. Imaeda, H. L. Ploegh, C. A. Janeway, and S. Tonegawa. 1993. TAP I-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 74:577.
19. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. M. Melief, C. Oseroff, L. Yuan, J. Ruppert et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586.
20. Chen, W., S. Khilko, J. Fecondo, D. H. Margulies, and J. McCluskey. 1994. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J. Exp. Med. 180:1471.
21. Van der Burg, S. H., M. J. W. Visseren, R. M. P. Brandt, W. M. Kast, and C. J. M. Melief. 1996. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability J. Immunol. 156:3308.
22. Levitsky, V., Q.-J. Zhang, J. Levitskaya, and M. G. Masucci. 1996. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J. Exp. Med. 183: 915.
23. Daly, K., P. Nguyen, D. L. Woodland, and M. A. Blackman. 1995. Immunodominance of major histocompatibility complex class-I restricted influenza virus epitopes can be influenced by the T-cell repertoire. J. Virol. 69:7416.
24. + CTL response to an influenza hemagglutinin epitope reflects limited T cell availability. J. Immunol. 157:505.
25. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus. In Fields Virology, Vol. 2, 3rd Ed. B. N. Fields, D. M. Knipe, and P. M. Howley, eds. Lippincott-Raven, Philadelphia, p. 2397.
26. Rickinson, A. B., and D. J. Moss. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15:405.
27. Murray, R. J., M. G. Kurilla, J. M. Brooks, W. A. Thomas, M. Rowe, E. Kieff, and A. B. Rickinson. 1992. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. Exp. Med. 176:157.
28. Brooks, J. M., R. Murray, W. A. Thomas, M. G. Kurilla, and A. B. Rickinson. 1993. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J. Exp. Med. 178:879.
29. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. G. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Séguin, P. S. Tuffnel, and B. G. Barrell. 1984. DNA sequence and expression of the B95.8 Epstein-Barr virus genome. Nature 310:207.
30. Doumas, B. T. 1975. Standards for total serum protein assays: a collaborative study. Clin. Chem. 21:1159.
31. Moss, D. J., I. S. Misko, S. R. Burrows, K. Burman, R. McCarthy, and T. B. Sculley. 1988. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants. Nature 331:719.
32. Lee, S. P., R. J. Tierney, W. A. Thomas, J. M. Brooks, and A. B. Rickinson. 1997. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. J. Immunol. 153:3325.
33. Burrows, S. R., A. Suhrbier, R. Khanna, and D. J. Moss. 1992. Rapid visual assay of cytotoxic T-cell specificity utilizing synthetic peptide induced T-cell-T-cell killing. Immunology 76:174.
34. Goulder, P. J. R., R. E. Phillips, R. A. Colbert, S. McAdam, G. Ogg, M. A. Nowak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, A. J. McMichael, and S. Rowland-Jones. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3:212.
35. Colbert, R. A., S. L. Rowland-Jones, A. J. McMichael, and J. A. Frelinger. 1994. Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity binding to B*2703. Immunity 1:121.
36. Pogue, R. R., J. Eron, J. A. Frelinger, and M. Matsui. 1995. Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity. Proc. Natl. Acad. Sci. USA 92:8166.
37. Hill, A. B., S. P. Lee, J. S. Haurum, N. Murray, Q. Y. Yao, M. Rowe, N. Signoret, A. B. Rickinson, and A. J. McMichael. 1995. Class I major histocompatibility-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV) nuclear antigens fail to lyse the EBV-transformed B lymphoblastoid lines against which they were raised. J. Exp. Med. 181:2221.
38. Boisgerault, F., V. Tieng, M. C. Stolzenberg, N. Dulphy, I. Khalil, R. Tamouza, D. Charron, and A. Toubert. 1996. Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants: implications for susceptibility to spondyloarthropathies. J. Clin. Invest. 98:2764.
39. Fiorillo, M. T., L. Meadows, M. D'Amato, J. Shabanowitz, D. F. Hunt, E. Appella, and R. Sorrentino. 1997. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes. Eur. J. Immunol. 27:368.
40. Lamas, J. R., J. M. Brooks, B. Galocha, A. B. Rickinson, and J. A. L-pez de Castro. 1998. Relationship between peptide binding and T cell epitope selection: a study with subtypes of HLA-B27. Int. Immunol. 10:259.
41. Obst, R., E. A. Armandola, M. Nijenhuis, F. Momburg, and G. J. Hämmerling. 1995. TAP polymorphism does not influence transport of peptide variants in mice and humans. Eur. J. Immunol. 25:2170.
42. Daniel, S., S. Caillat-Zucman, J. Hammer, J.-F. Bach, and P. M. van Endert. 1997. Absence of functional relevance of human transporter associated with antigen processing polymorphism for peptide selection. J. Immunol. 159:2350.
43. Griffin, T. A., J. Yuan, T. Friede, S. Stevanovic, K. Ariyoshi, S. L. Rowland-Jones, H.-G. Rammensee, and R. A. Colbert. 1997. Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides. J. Immunol. 159:4887.
44. Sjits, A. J. A. M., and E. G. Pamer. 1997. Enhanced intracellular dissociation of major histocompatibility complex class I-associated peptides: a mechanism for optimizing the spectrum of cell surface-presented cytotoxic T lymphocyte epitopes. J. Exp. Med. 185:1403.
45. Levitsky, V., Q.-J. Zhang, J. Levitskaya, M. G. Kurilla, and M. G. Masucci. 1997. Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexes. J. Immunol. 159:5383.